Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
19.10
+0.59 (3.19%)
At close: Jun 5, 2025, 4:00 PM
19.34
+0.24 (1.26%)
After-hours: Jun 5, 2025, 7:00 PM EDT
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of $2.40 billion as of June 5, 2025. Its market cap has decreased by -52.12% in one year.
Market Cap
2.40B
Enterprise Value
2.51B
1-Year Change
-52.12%
Ranking
Category
Stock Price
$19.10
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.07M to $2.40B, an increase of 247.36%. That is a compound annual growth rate of 17.87%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 686.22B |
Johnson & Johnson | 369.02B |
AbbVie | 332.08B |
Novo Nordisk | 324.15B |
UnitedHealth Group | 270.51B |
Abbott Laboratories | 232.29B |
Novartis AG | 229.87B |
AstraZeneca | 226.47B |